Skip to main content
Premium Trial:

Request an Annual Quote

Jeremy Berg, Jim Golden, Roger Perlmutter

Premium

Jeremy Berg, currently director of the Institute for Basic Biomedical Sciences and professor and director of the department of biophysics and biophysical chemistry at Johns Hopkins University School of Medicine in Baltimore, has been named as the new director of the National Institute of General Medical Sciences.

Berg, who is expected to begin his new position in early November, will replace Judith Greenberg, who became acting director of NIGMS in May 2002 following the departure of Marvin Cassman, who had led the institute since 1993.

Jim Golden, formerly business development manager of Curagen’s sequencing technology spin-off, 454, has joined Cambridge Healthtech Institute as senior vice president and research director.

The Institute for Systems Biology has appointed Roger Perlmutter as chairman of its board of directors. Perlmutter currently serves as executive vice president of R&D at Amgen. He has been a member of ISB’s board since its inception in January 2000.

Filed under

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more